{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:08:09Z","timestamp":1789088889169,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018540","name":"Science Fund for Distinguished Young Scholars of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515010216"],"award-info":[{"award-number":["2023A1515010216"]}],"id":[{"id":"10.13039\/501100018540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022B1515120074"],"award-info":[{"award-number":["2022B1515120074"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010843","name":"Guangzhou Science, Technology and Innovation Commission","doi-asserted-by":"publisher","award":["2024A03J1175"],"award-info":[{"award-number":["2024A03J1175"]}],"id":[{"id":"10.13039\/501100010843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Turner syndrome (TS) is associated with cardiovascular abnormalities and metabolic risk, but karyotype-specific phenotypes remain incompletely defined, particularly in pediatric and adolescent cohorts assessed by transthoracic echocardiography (TTE).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a retrospective cross-sectional study of 289 patients with TS evaluated between October 2016 and October 2023. Patients were grouped as 45,X monosomy (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009149) or mosaic\/structural karyotypes (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009140). Baseline or preoperative TTE data were used. The primary endpoint was a clinically relevant structural cardiovascular disease (CVD) composite based on explicit baseline\/preoperative diagnoses of major lesions; patent foramen ovale, isolated persistent left superior vena cava, and minor valve regurgitation were treated as descriptive findings. Aortic dilatation based on ASI\u2009&gt;\u200920\u00a0mm\/m\u00b2 was analyzed separately as an aortic-size phenotype.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The structural CVD composite was more frequent in the 45,X group than in the mosaic\/structural group (49\/149 [32.9%] vs. 26\/140 [18.6%],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.006). In multivariable logistic regression, 45,X remained associated with the structural CVD composite after adjustment for age, BMI, systolic blood pressure, LDL-C, and HOMA-IR (OR 1.88, 95% CI 1.05\u20133.35;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.033). Aortic dilatation by ASI\u2009&gt;\u200920\u00a0mm\/m\u00b2 did not differ significantly between groups (28.9% vs. 32.9%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.462). Elevated total cholesterol was more frequent in the 45,X group, and LDL-C was independently associated with the structural CVD composite. LVDD was modestly lower in the 45,X group (33.6\u2009\u00b1\u20096.6 vs. 35.4\u2009\u00b1\u20096.4\u00a0mm;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.017).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this single-center TS cohort, 45,X monosomy was associated with a higher burden of clinically relevant structural cardiovascular abnormalities and an adverse lipid profile, whereas ASI-defined aortic dilatation alone did not differ significantly by karyotype. These findings support karyotype-aware cardiovascular surveillance, while underscoring the need for cautious interpretation of small TTE differences and validation in multicenter longitudinal studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04457-5","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T09:44:42Z","timestamp":1781948682000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Karyotype-specific cardiovascular and metabolic profiles in Turner syndrome: a retrospective echocardiographic study"],"prefix":"10.1186","volume":"21","author":[{"given":"Yinchun","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaomin","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinsheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gendie E.","family":"Lash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8832-0575","authenticated-orcid":false,"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"issue":"7075","key":"4457_CR1","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0140-6736(","volume":"1","author":"CE Ford","year":"1959","unstructured":"Ford CE, Jones KW, Polani PE, De Almeida JC, Briggs JH. A sex-chromosome anomaly in a case of gonadal dysgenesis (Turner\u2019s syndrome). Lancet. 1959;1(7075):711\u20133. https:\/\/doi.org\/10.1016\/S0140-6736(. 59)91893-8 PubMed PMID: 13642858IF: 88.5 Q1 B1.","journal-title":"Lancet"},{"issue":"6","key":"4457_CR2","doi-asserted-by":"publisher","first-page":"G53","DOI":"10.1093\/ejendo\/lvae050","volume":"190","author":"CH Gravholt","year":"2024","unstructured":"Gravholt CH, Andersen NH, Christin-Maitre S, Davis SM, Duijnhouwer A, Gawlik A, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome. Eur J Endocrinol. 2024;190(6):G53\u2013151. https:\/\/doi.org\/10.1093\/ejendo\/lvae050 . PubMed PMID: 38748847IF: 5.2 Q1 B2; PubMed Central PMCID: PMC11759048IF: 5.2 Q1 B2.","journal-title":"Eur J Endocrinol"},{"key":"4457_CR3","doi-asserted-by":"publisher","unstructured":"Gravholt CH, Andersen NH, Conway GS, Dekkers OM, Geffner ME, Klein KO et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017;177(3):G1-G70. https:\/\/doi.org\/10.1530\/EJE-17-0430 PubMed PMID: 28705803IF: 5.2 Q1 B2.","DOI":"10.1530\/EJE-17-0430"},{"issue":"1","key":"4457_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1210\/endrev\/bnac016","volume":"44","author":"CH Gravholt","year":"2023","unstructured":"Gravholt CH, Viuff M, Just J, Sandahl K, van der Brun S, et al. The Changing Face of Turner Syndrome. Endocr Rev. 2023;44(1):33\u201369. https:\/\/doi.org\/10.1210\/endrev\/bnac016 . PubMed PMID: 35695701IF: 22.0 Q1 B1.","journal-title":"Endocr Rev"},{"issue":"10","key":"4457_CR5","doi-asserted-by":"publisher","first-page":"e000048","DOI":"10.1161\/HCG.0000000000000048","volume":"11","author":"M Silberbach","year":"2018","unstructured":"Silberbach M, Roos-Hesselink JW, Andersen NH, Braverman AC, Brown N, Collins RT, et al. Cardiovascular Health in Turner Syndrome: A Scientific Statement From the American Heart Association. Circ Genom Precis Med. 2018;11(10):e000048. 10. 1161\/HCG.0000000000000048 PubMed PMID: 30354301IF: 5.5 Q1 B2.","journal-title":"Circ Genom Precis Med"},{"key":"4457_CR6","doi-asserted-by":"publisher","unstructured":"Bondy CA. Congenital cardiovascular disease in Turner syndrome. Congenit Heart Dis. 2008 Jan-Feb;3(1):2\u201315. https:\/\/doi.org\/10.1111\/j.1747-0803.2007.00163. x PubMed PMID: 18373744IF: 1.2 Q4 B4.","DOI":"10.1111\/j.1747-0803.2007.00163"},{"issue":"19","key":"4457_CR7","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.jacc","volume":"51","author":"V Sachdev","year":"2008","unstructured":"Sachdev V, Matura LA, Sidenko S, Ho VB, Arai AE, Rosing DR, et al. Aortic valve disease in Turner syndrome. J Am Coll Cardiol. 2008;51(19):1904\u20139. https:\/\/doi.org\/10.1016\/j.jacc. 2008.02.035 PubMed PMID: 18466808IF: 22.3 Q1 B1.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"4457_CR8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1530\/EJE-12-0434","volume":"167","author":"B Donadille","year":"2012","unstructured":"Donadille B, Rousseau A, Zenaty D, Cabrol S, Courtillot C, Samara-Boustani D, et al. Cardiovascular findings and management in Turner syndrome: insights from a French cohort. Eur J Endocrinol. 2012;167(4):517\u201322. 10.1530. \/EJE-12-0434 PubMed PMID: 22802424IF: 5.2 Q1 B2.","journal-title":"Eur J Endocrinol"},{"key":"4457_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2024.11.007","volume":"281","author":"S Thunstr\u00f6m","year":"2025","unstructured":"Thunstr\u00f6m S, Thunstr\u00f6m E, Naess\u00e9n S, Berntorp K, Laczna Kitlinski M, Ekman B, et al. All-cause mortality and death by aortic dissection in women with Turner syndrome: A national clinical cohort study. Am Heart J. 2025;281:1\u20139. 007 PubMed PMID: 39603484IF: 3.5 Q2 B2.","journal-title":"Am Heart J"},{"issue":"12","key":"4457_CR10","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.1210\/jc.2008-1049","volume":"93","author":"MJ Schoemaker","year":"2008","unstructured":"Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA. Mortality in women with turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab. 2008;93(12):4735\u201342. https:\/\/doi.org\/10.1210\/jc.2008-1049 . PubMed PMID: 18812477IF: 5.1 Q1 B2.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"4457_CR11","doi-asserted-by":"publisher","first-page":"e011501","DOI":"10.1161\/JAHA.118.011501","volume":"8","author":"MM Fuchs","year":"2019","unstructured":"Fuchs MM, Attenhofer Jost C, Babovic-Vuksanovic D, Connolly HM, Egbe A. Long-Term Outcomes in Patients With Turner Syndrome: A 68-Year Follow-Up. J Am Heart Assoc. 2019;8(11):e011501. https:\/\/doi.org\/10.1161\/JAHA.118.011501 . PubMed PMID: 31131660IF: 5.3 Q1 B1; PubMed Central PMCID: PMC6585378IF: 5.3 Q1 B1.","journal-title":"J Am Heart Assoc"},{"issue":"Suppl 1","key":"4457_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s13023-022-02423-5","volume":"17","author":"E Fiot","year":"2022","unstructured":"Fiot E, Alauze B, Donadille B, Samara-Boustani D, Houang M, De Filippo G, et al. Turner syndrome: French National Diagnosis and Care Protocol (NDCP; National Diagnosis and Care Protocol). Orphanet J Rare Dis. 2022;17(Suppl 1):261. https:\/\/doi.org\/10.1186\/s13023-022-02423-5 . PubMed PMID: 35821070IF: 3.5 Q2 B2; PubMed Central PMCID: PMC9277788IF: 3.5 Q2 B2.","journal-title":"Orphanet J Rare Dis"},{"issue":"24","key":"4457_CR13","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1161\/CIR","volume":"146","author":"EM Isselbacher","year":"2022","unstructured":"Isselbacher EM, Preventza O, Hamilton Black J 3rd, Augoustides JG, Beck AW, Bolen MA, et al. 2022 ACC\/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2022;146(24):e334\u2013482. https:\/\/doi.org\/10.1161\/CIR. 0000000000001106 PubMed PMID: 36322642IF: 38.6 Q1 B1; PubMed Central PMCID: PMC9876736IF: 38.6 Q1 B1.","journal-title":"Circulation"},{"issue":"5","key":"4457_CR14","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1017\/S1047951115002735","volume":"26","author":"KH Mortensen","year":"2016","unstructured":"Mortensen KH, Gopalan D, N\u00f8rgaard BL, Andersen NH, Gravholt CH. Multimodality cardiac imaging in Turner syndrome. Cardiol Young. 2016;26(5):831\u201341. https:\/\/doi.org\/10.1017\/S1047951115002735 PubMed PMID: 26843123IF: 0.7 Q4 B4.","journal-title":"Cardiol Young"},{"issue":"1","key":"4457_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo","volume":"32","author":"C Mitchell","year":"2019","unstructured":"Mitchell C, Rahko PS, Blauwet LA, Canaday B, Finstuen JA, Foster MC, et al. Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2019;32(1):1\u201364. https:\/\/doi.org\/10.1016\/j.echo. 2018.06.004 PubMed PMID: 30282592IF: 6.0 Q1 B1.","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"4457_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3906\/sag-1511-3","volume":"47","author":"H Yi\u011fit","year":"2017","unstructured":"Yi\u011fit H, \u00d6nder A, \u00d6zg\u00fcr S, Aycan Z, Karademir S, Do\u011fan V. Cardiac MRI and 3D contrast-enhanced MR angiography in pediatric and young adult patients with Turner syndrome. Turk J Med Sci. 2017;47(1):127\u201333. https:\/\/doi.org\/10.3906\/sag-1511-3 . PubMed PMID: 28263479IF: 1.0 Q3 B4.","journal-title":"Turk J Med Sci"},{"issue":"2","key":"4457_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/ajmg.c.32146","volume":"199","author":"F \u00c1lvarez-Nava","year":"2025","unstructured":"\u00c1lvarez-Nava F, Crenshaw ML, Bedei I, Soto M, Maciel-Guerra AT, Skakkeb\u00e6k A. The Impact of Karyotype on Congenital Heart Diseases in Turner Syndrome: A Systematic Review and Meta-Analysis. Am J Med Genet C Semin Med Genet. 2025;199(2):93\u2013106. https:\/\/doi.org\/10.1002\/ajmg.c.32146 . PubMed PMID: 40557696IF: 4.4 Q1 B3.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"7","key":"4457_CR18","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s00246-023-03159-0","volume":"45","author":"A Birjiniuk","year":"2024","unstructured":"Birjiniuk A, Weisman AG, Laternser C, Camarda J, Brickman WJ, Habiby R, et al. Cardiovascular Manifestations of Turner Syndrome: Phenotypic Differences Between Karyotype Subtypes. Pediatr Cardiol. 2024;45(7):1407\u201314. https:\/\/doi.org\/10.1007\/s00246-023-03159-0 . PubMed PMID: 37147524IF: 1.4 Q3 B4.","journal-title":"Pediatr Cardiol"},{"key":"4457_CR19","doi-asserted-by":"publisher","unstructured":"Prandstraller D, Mazzanti L, Picchio FM, Magnani C, Bergamaschi R, Perri A, et al. Turner\u2019s syndrome: cardiologic profile according to the different chromosomal patterns and long-term clinical follow-Up of 136 nonpreselected patients. Pediatr Cardiol. 1999 Mar-Apr;20(2):108\u201312. https:\/\/doi.org\/10.1007\/s002469900416 PubMed PMID: 9986886IF: 1.4 Q3 B4.","DOI":"10.1007\/s002469900416"},{"issue":"6","key":"4457_CR20","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/uog.14627","volume":"45","author":"E Kl\u00e1skov\u00e1","year":"2015","unstructured":"Kl\u00e1skov\u00e1 E, T\u00fcd\u00f6s Z, Sobek A, Zapletalov\u00e1 J, Dost\u00e1l J, Zbo\u0159ilov\u00e1 B, et al. Low-level 45, X\/46, XX mosaicism is not associated with congenital heart disease and thoracic aorta dilatation: prospective magnetic resonance imaging and ultrasound study. Ultrasound Obstet Gynecol. 2015;45(6):722\u20137. https:\/\/doi.org\/10.1002\/uog.14627 . PubMed PMID: 25042300IF: 6.3 Q1 B1.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"4457_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1530\/EJE-18-0878","volume":"180","author":"E Fiot","year":"2019","unstructured":"Fiot E, Z\u00e9naty D, Boizeau P, Haignere J, Dos Santos S, L\u00e9ger J. X chromosome gene dosage as a determinant of congenital malformations and of age-related comorbidity risk in patients with Turner syndrome, from childhood to early adulthood. Eur J Endocrinol. 2019;180(6):397\u2013406. 10.1530. \/EJE-18-0878 PubMed PMID: 30991358IF: 5.2 Q1 B2.","journal-title":"Eur J Endocrinol"},{"key":"4457_CR22","doi-asserted-by":"publisher","first-page":"1324160","DOI":"10.3389\/fendo.2024.1324160","volume":"15","author":"G Wang","year":"2024","unstructured":"Wang G, Liu X, Wang M, Wang J, Zhang Z, Allegaert K, et al. Evaluating the relationship between the proportion of X-chromosome deletions and clinical manifestations in children with turner syndrome. Front Endocrinol (Lausanne). 2024;15:1324160. https:\/\/doi.org\/10.3389\/fendo.2024.1324160 . PubMed PMID: 38481442IF: 4.6 Q1 B3; PubMed Central PMCID: PMC10933015IF: 4.6 Q1 B3.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"4457_CR23","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0022-3476(","volume":"126","author":"JL Ross","year":"1995","unstructured":"Ross JL, Feuillan P, Long LM, Kowal K, Kushner H, Cutler GB Jr. Lipid abnormalities in Turner syndrome. J Pediatr. 1995;126(2):242\u20135. https:\/\/doi.org\/10.1016\/S0022-3476(. 95)70551-1 PubMed PMID: 7844670IF: 3.5 Q1 B2.","journal-title":"J Pediatr"},{"issue":"11","key":"4457_CR24","doi-asserted-by":"publisher","first-page":"bvad124","DOI":"10.1210\/jendso\/bvad124","volume":"7","author":"KJ Sandahl","year":"2023","unstructured":"Sandahl KJ, Just J, Erlandsen M, Mortensen KH, Andersen NH, Gravholt CH. A Prospective Study of Lipids in Adult Women With Turner Syndrome. J Endocr Soc. 2023;7(11):bvad124. https:\/\/doi.org\/10.1210\/jendso\/bvad124 . PubMed PMID: 37822574IF: 3.1 Q2 B3; PubMed Central PMCID: PMC10563659IF: 3.1 Q2 B3.","journal-title":"J Endocr Soc"},{"key":"4457_CR25","doi-asserted-by":"publisher","first-page":"1216464","DOI":"10.3389\/fendo.2023.1216464","volume":"14","author":"E B\u0142aszczyk","year":"2023","unstructured":"B\u0142aszczyk E, Shulhai AM, Gieburowska J, Bara\u0144ski K, Gawlik AM. Components of the metabolic syndrome in girls with Turner syndrome treated with growth hormone in a long term prospective study. Front Endocrinol (Lausanne). 2023;14:1216464. https:\/\/doi.org\/10.3389\/fendo.2023.1216464 . PubMed PMID: 37497348IF: 4.6 Q1 B3; PubMed Central PMCID: PMC10367090IF: 4.6 Q1 B3.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"4457_CR26","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1210\/clinem\/dgae357","volume":"110","author":"A Cameron-Pimblett","year":"2025","unstructured":"Cameron-Pimblett A, La Rosa C, Davies MC, Suntharalingham JP, Ishida M, Achermann JC, et al. Characterization of Turner Syndrome-associated Diabetes Mellitus. J Clin Endocrinol Metab. 2025;110(5):1279\u201386. https:\/\/doi.org\/10.1210\/clinem\/dgae357 . PubMed PMID: 38961758IF: 5.1 Q1 B2; PubMed Central PMCID: PMC12012693IF: 5.1 Q1 B2.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4457_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0022-3476(","volume":"93","author":"GB Haycock","year":"1978","unstructured":"Haycock GB, Schwartz GJ, Wisotsky DH. Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr. 1978;93(1):62\u20136. https:\/\/doi.org\/10.1016\/S0022-3476(. 78)80601-5 PubMed PMID: 650346IF: 3.5 Q1 B2.","journal-title":"J Pediatr"},{"issue":"Suppl 5","key":"4457_CR28","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.1542\/peds.2009-2107","volume":"128","author":"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute","year":"2011","unstructured":"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128(Suppl 5):S213\u201356. https:\/\/doi.org\/10.1542\/peds.2009-2107. C PubMed PMID: 22084329IF: 6.4 Q1 B2; PubMed Central PMCID: PMC4536582IF: 6.4 Q1 B2.","journal-title":"Pediatrics"},{"issue":"7","key":"4457_CR29","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139. https:\/\/doi.org\/10.1007\/BF00280883 . PubMed PMID: 3899825IF: 10.2 Q1 B1.","journal-title":"Diabetologia"},{"issue":"4","key":"4457_CR30","doi-asserted-by":"publisher","first-page":"e500","DOI":"10.1542\/peds.2004-1921","volume":"115","author":"M Keskin","year":"2005","unstructured":"Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose\/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2005;115(4):e500\u20133. https:\/\/doi.org\/10.1542\/peds.2004-1921 . PubMed PMID: 15741351IF: 6.4 Q1 B2.","journal-title":"Pediatrics"},{"issue":"6","key":"4457_CR31","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/diacare.27","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487\u201395. https:\/\/doi.org\/10.2337\/diacare.27. 6.1487 PubMed PMID: 15161807IF: 16.6 Q1 B1.","journal-title":"Diabetes Care"},{"issue":"5","key":"4457_CR32","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.echo.2010","volume":"23","author":"L Lopez","year":"2010","unstructured":"Lopez L, Colan SD, Frommelt PC, Ensing GJ, Kendall K, Younoszai AK, et al. Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr. 2010;23(5):465\u201395. https:\/\/doi.org\/10.1016\/j.echo.2010. quiz 576-7.","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"4457_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1\u2013e3914. https:\/\/doi.org\/10.1016\/j.echo.2014.10.003 . PubMed PMID: 25559473IF: 6.0 Q1 B1.","journal-title":"J Am Soc Echocardiogr"},{"issue":"2","key":"4457_CR34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/heartjnl-2022-320922","volume":"109","author":"F Meccanici","year":"2023","unstructured":"Meccanici F, Schotte MH, Snoeren M, van den Bons LR, Kardys I, et al. Aortic dilation and growth in women with Turner syndrome. Heart. 2023;109(2):102\u201310. https:\/\/doi.org\/10.1136\/heartjnl-2022-320922 . PubMed PMID: 35705330IF: 4.4 Q1 B2.","journal-title":"Heart"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04457-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04457-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04457-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:18:22Z","timestamp":1789085902000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04457-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4457"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04457-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was reviewed and approved by the Scientific Research Ethics Committee of Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University (approval No. Sui Fu Er Ke Lun Pi Zi [2025] No. 261A01; approval date: 14 August 2025). Informed consent was obtained from participants and\/or their legal guardians in accordance with the approved protocol. All data were analyzed in aggregate form without identifying individual participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent for the publication of data was obtained from all participants or their legal caregivers.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"315"}}